These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34884511)

  • 1. Effects of the Combined Treatment with a G-Quadruplex-Stabilizing Ligand and Photon Beams on Glioblastoma Stem-like Cells: A Magnetic Resonance Study.
    Palma A; Grande S; Luciani AM; Ricci-Vitiani L; Buccarelli M; Pallini R; Triveri A; Pirota V; Doria F; D'Alessandris QG; Berardinelli F; Antoccia A; Rosi A
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-quadruplex ligand RHPS4 radiosensitizes glioblastoma xenograft in vivo through a differential targeting of bulky differentiated- and stem-cancer cells.
    Berardinelli F; Tanori M; Muoio D; Buccarelli M; di Masi A; Leone S; Ricci-Vitiani L; Pallini R; Mancuso M; Antoccia A
    J Exp Clin Cancer Res; 2019 Jul; 38(1):311. PubMed ID: 31311580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The G-quadruplex-stabilizing ligand RHPS4 enhances sensitivity of U251MG glioblastoma cells to clinical carbon ion beams.
    Berardinelli F; Sgura A; Facoetti A; Leone S; Vischioni B; Ciocca M; Antoccia A
    FEBS J; 2018 Apr; 285(7):1226-1236. PubMed ID: 29484821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different Mechanisms Underlie the Metabolic Response of GBM Stem-Like Cells to Ionizing Radiation: Biological and MRS Studies on Effects of Photons and Carbon Ions.
    Palma A; Grande S; Ricci-Vitiani L; Luciani AM; Buccarelli M; Biffoni M; Dini V; Cirrone GAP; Ciocca M; Guidoni L; Pallini R; Viti V; Rosi A
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The G-quadruplex-stabilising agent RHPS4 induces telomeric dysfunction and enhances radiosensitivity in glioblastoma cells.
    Berardinelli F; Siteni S; Tanzarella C; Stevens MF; Sgura A; Antoccia A
    DNA Repair (Amst); 2015 Jan; 25():104-15. PubMed ID: 25467559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere targeting with a new G4 ligand enhances radiation-induced killing of human glioblastoma cells.
    Merle P; Evrard B; Petitjean A; Lehn JM; Teulade-Fichou MP; Chautard E; De Cian A; Guittat L; Tran PL; Mergny JL; Verrelle P; Tchirkov A
    Mol Cancer Ther; 2011 Oct; 10(10):1784-95. PubMed ID: 21987532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.
    Kahn J; Hayman TJ; Jamal M; Rath BH; Kramp T; Camphausen K; Tofilon PJ
    Neuro Oncol; 2014 Jan; 16(1):29-37. PubMed ID: 24311635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Radiosensitizing Effect of AZD0530 in Glioblastoma and Glioblastoma Stem-Like Cells.
    Yun HS; Lee J; Kil WJ; Kramp TR; Tofilon PJ; Camphausen K
    Mol Cancer Ther; 2021 Sep; 20(9):1672-1679. PubMed ID: 34158343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide sensitizes cancer stem cells to chemoradiotherapy. A new approach in the treatment of inoperable glioblastoma multiforme.
    Tomuleasa C; Soritau O; Kacso G; Fischer-Fodor E; Cocis A; Ioani H; Timis T; Petrescu M; Cernea D; Virag P; Irimie A; Florian IS
    J BUON; 2010; 15(4):758-62. PubMed ID: 21229642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioblastoma stem cells: radiobiological response to ionising radiations of different qualities.
    Pecchia I; Dini V; Ricci-Vitiani L; Biffoni M; Balduzzi M; Fratini E; Belli M; Campa A; Esposito G; Cirrone G; Romano F; Stancampiano C; Pelacchi F; Pallini R; Tabocchini MA
    Radiat Prot Dosimetry; 2015 Sep; 166(1-4):374-8. PubMed ID: 25969527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High linear-energy-transfer radiation can overcome radioresistance of glioma stem-like cells to low linear-energy-transfer radiation.
    Hirota Y; Masunaga S; Kondo N; Kawabata S; Hirakawa H; Yajima H; Fujimori A; Ono K; Kuroiwa T; Miyatake S
    J Radiat Res; 2014 Jan; 55(1):75-83. PubMed ID: 23955054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly efficient radiosensitization of human glioblastoma and lung cancer cells by a G-quadruplex DNA binding compound.
    Merle P; Gueugneau M; Teulade-Fichou MP; Müller-Barthélémy M; Amiard S; Chautard E; Guetta C; Dedieu V; Communal Y; Mergny JL; Gallego M; White C; Verrelle P; Tchirkov A
    Sci Rep; 2015 Nov; 5():16255. PubMed ID: 26542881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitivity of Patient-Derived Glioma Stem Cell 3-Dimensional Cultures to Photon, Proton, and Carbon Irradiation.
    Chiblak S; Tang Z; Campos B; Gal Z; Unterberg A; Debus J; Herold-Mende C; Abdollahi A
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):112-119. PubMed ID: 26254681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of checkpoint kinase 1 is associated with the increased radiosensitivity of glioblastoma stem-like cells.
    Wu J; Lai G; Wan F; Xiao Z; Zeng L; Wang X; Ye F; Lei T
    Tohoku J Exp Med; 2012 Apr; 226(4):267-74. PubMed ID: 22481303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchrotron-based photon activation therapy effect on cisplatin pre-treated human glioma stem cells.
    Ceresa C; Nicolini G; Semperboni S; Requardt H; Le Duc G; Santini C; Pellei M; Bentivegna A; Dalprà L; Cavaletti G; Bravin A
    Anticancer Res; 2014 Oct; 34(10):5351-5. PubMed ID: 25275028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
    Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-derived glioblastoma stem cells respond differentially to targeted therapies.
    Kanabur P; Guo S; Simonds GR; Kelly DF; Gourdie RG; Verbridge SS; Sheng Z
    Oncotarget; 2016 Dec; 7(52):86406-86419. PubMed ID: 27863440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma.
    Aderetti DA; Hira VVV; Molenaar RJ; van Noorden CJF
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):346-354. PubMed ID: 29684521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells.
    Guerriero C; Matera C; Del Bufalo D; De Amici M; Conti L; Dallanoce C; Tata AM
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.